editorial | Q871232 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/14651858.ED000075 |
P8608 | Fatcat ID | release_kgkozhyj3ja6nkr536xb3ct7ru |
P3181 | OpenCitations bibliographic resource ID | 1759602 |
P698 | PubMed publication ID | 24575439 |
P50 | author | Lisa Bero | Q16192607 |
P2860 | cites work | Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others | Q21563421 |
Industry sponsorship and research outcome | Q24202591 | ||
The cycle of bias in health research: a framework and toolbox for critical appraisal training | Q24289237 | ||
Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? | Q26701411 | ||
Outcome reporting in industry-sponsored trials of gabapentin for off-label use | Q28264491 | ||
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses | Q34116483 | ||
Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study | Q34294990 | ||
Design and reporting modifications in industry-sponsored comparative psychopharmacology trials | Q34925731 | ||
Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? | Q42778090 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | research funding | Q372353 |
bias | Q742736 | ||
P577 | publication date | 2013-12-20 | |
P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
P1476 | title | Why the Cochrane Risk of Bias Tool Should Include Funding Source as a Standard Item |
Q24186168 | Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents |
Q38760549 | Antiplatelet pretreatment and outcomes in intravenous thrombolysis for stroke: a systematic review and meta-analysis. |
Q34299192 | Assessing bias in osteoarthritis trials included in Cochrane reviews: protocol for a meta-epidemiological study |
Q90280198 | Associations between industry involvement and study characteristics at the time of trial registration in biomedical research |
Q26471696 | Buffered solutions versus isotonic saline for resuscitation in non-surgical critically ill adults and children |
Q36887082 | Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews |
Q36456218 | Evidence from Toxicology: The Most Essential Science for Prevention |
Q36994018 | How credible are the study results? Evaluating and applying internal validity tools to literature-based assessments of environmental health hazards |
Q34264322 | Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol. |
Q24186383 | Interventions for rosacea |
Q42317700 | Marketing trials, marketing tricks - how to spot them and how to stop them |
Q22061981 | Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) |
Q94348315 | Pharmacological interventions for people with borderline personality disorder |
Q93131144 | Prevalence of common mental health disorders in adults who are high or costly users of healthcare services: protocol for a systematic review and meta-analysis |
Q33456912 | Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank |
Q47259028 | Randomized clinical trials in dentistry: Risks of bias, risks of random errors, reporting quality, and methodologic quality over the years 1955-2013. |
Q34047368 | Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews |
Q91736607 | Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009 |
Q46070038 | Response to correspondence by Heather Lynch, Julie Goodman and Nancy Beck Re: "Application of the Navigation Guide systematic review methodology to the evidence for developmental and reproductive toxicity of triclosan". |
Q38652686 | Systematic review of community health impacts of mountaintop removal mining |
Q24187313 | Systemic antibiotics for treating diabetic foot infections |
Q26773978 | The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis |
Q34275367 | The Navigation Guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. |
Q34275302 | The Navigation Guide systematic review methodology: a rigorous and transparent method for translating environmental health science into better health outcomes |
Q26824991 | The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis |
Q36211674 | The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis |
Q53968720 | The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed. |
Q64053550 | The judgement of biases included in the category "other bias" in Cochrane systematic reviews of interventions: a systematic survey |
Q33898415 | The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials |
Q34045690 | The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis |
Q58770735 | The reporting of funding in health policy and systems research: a cross-sectional study |
Q28393577 | Use of a modified GreenScreen tool to conduct a screening-level comparative hazard assessment of conventional silver and two forms of nanosilver |
Q55714559 | Using risk of bias domains to identify opportunities for improvement in food- and nutrition-related research: An evaluation of research type and design, year of publication, and source of funding. |